These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24845027)

  • 1. Comprehensive assessment of the association between XPD rs13181 polymorphism and lung cancer risk.
    Wu HY; Ding LY
    Tumour Biol; 2014 Aug; 35(8):8125-32. PubMed ID: 24845027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
    Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
    World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
    Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
    Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Cui J; Li D; Shen L; Zhang W; Xu X
    Tumour Biol; 2014 Jul; 35(7):6335-41. PubMed ID: 24652592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
    Nairuz T; Rahman M; Bushra MU; Kabir Y
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
    Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
    Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
    Yuan H; Niu YM; Wang RX; Li HZ; Chen N
    Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.
    Ding DP; Ma WL; He XF; Zhang Y
    Mol Biol Rep; 2012 Mar; 39(3):2533-40. PubMed ID: 21667112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
    Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
    Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.
    Zhou Q; Fu Y; Wen L; Deng Y; Chen J; Liu K
    Technol Cancer Res Treat; 2021; 20():1533033821990046. PubMed ID: 33517857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between XPD rs13181 and rs1799793 polymorphism and oral cancer risk: evidence from a meta-analysis.
    Zeng W; Xu W; Long W
    BMC Cancer; 2024 Jun; 24(1):738. PubMed ID: 38879503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies.
    Wang F; Chang D; Hu FL; Sui H; Han B; Li DD; Zhao YS
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):507-17. PubMed ID: 18349268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.
    Li C; Jiang Z; Liu X
    Mol Biol Rep; 2010 Jan; 37(1):301-9. PubMed ID: 19669592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.
    Zhan P; Wang Q; Wei SZ; Wang J; Qian Q; Yu LK; Song Y
    J Thorac Oncol; 2010 Sep; 5(9):1337-45. PubMed ID: 20651612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.
    Lin H; Lin D; Zheng C
    Diagn Pathol; 2014 Jan; 9():15. PubMed ID: 24443924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.
    Li SX; Dai QS; Chen SX; Zhang SD; Liao XY; Deng X; Chi HB; Li FJ; Zhu JH; Jiang YY
    Tumour Biol; 2014 Apr; 35(4):3905-15. PubMed ID: 24347488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.
    Hu Z; Wei Q; Wang X; Shen H
    Lung Cancer; 2004 Oct; 46(1):1-10. PubMed ID: 15364127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.